REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 87 filers reported holding REGENXBIO INC in Q2 2017. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373,543 | +43.1% | 22,694 | +73.8% | 0.00% | +33.3% |
| Q2 2023 | $260,969 | +54155.5% | 13,055 | -48.7% | 0.00% | -57.1% |
| Q1 2023 | $481 | +90.9% | 25,452 | +129.1% | 0.01% | +40.0% |
| Q4 2022 | $252 | -99.9% | 11,110 | -20.1% | 0.01% | -37.5% |
| Q3 2022 | $367,000 | -10.3% | 13,901 | +12.9% | 0.01% | -20.0% |
| Q1 2022 | $409,000 | -6.2% | 12,317 | -3.5% | 0.01% | +11.1% |
| Q1 2021 | $436,000 | -55.5% | 12,768 | -74.8% | 0.01% | -70.0% |
| Q1 2017 | $979,000 | +42.7% | 50,730 | +62.9% | 0.03% | +30.4% |
| Q3 2015 | $686,000 | – | 31,150 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 839,139 | $35,177,000 | 6.39% |
| Sonic Fund II, L.P. | 188,786 | $7,914,000 | 4.47% |
| ArchPoint Investors | 297,355 | $12,465,000 | 3.73% |
| Redmile Group, LLC | 2,008,001 | $84,175,000 | 1.47% |
| RTW INVESTMENTS, LP | 1,845,366 | $77,358,000 | 1.17% |
| WS MANAGEMENT LLLP | 210,729 | $8,834,000 | 0.94% |
| FRAZIER MANAGEMENT LLC | 235,809 | $9,885,000 | 0.79% |
| Integral Health Asset Management, LLC | 55,000 | $2,306,000 | 0.66% |
| Sofinnova Investments, Inc. | 127,593 | $5,349,000 | 0.32% |
| HHLR ADVISORS, LTD. | 456,000 | $19,116,000 | 0.25% |